LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - ProMIS Neurosciences (NASDAQ: PMN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PMN ProMIS Neurosciences
ABG Management Ltd. / 10 percent owner
10/22/2025
Buy
$0.45
40,000
$18K
40,000